(Q45847558)

English

A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition

scientific article published on 20 February 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

1 reference

ChEBI release 2020-05-28

author name string

E L Theunissen

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

D Street

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

A-M Højer

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

A Vermeeren

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

A van Oers

5

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

J G Ramaekers

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

language of work or name

0 references

publication date

20 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

93

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

493-501

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

Effects of antidepressants on cognitive functions: a review

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Cognitive deficits in depression: possible implications for functional neuropathology

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Productivity losses among treated depressed patients relative to healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Absenteeism among employees treated for depression.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Diazepam impairs lateral position control in highway driving.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Effects of mefloquine alone and with alcohol on psychomotor and driving performance.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A Review of the Pharmacological and Clinical Profile of Mirtazapine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Tolerability and safety aspects of mirtazapine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

P.2.b.015 Lu AA21004: a novel potential treatment for mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

21 January 2018

Psychoactive medications and injurious motor vehicle collisions involving older drivers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Considering the P450 cytochrome system as determining combined effects of antidepressants and benzodiazepines on actual driving performance of depressed outpatients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2013.39

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23588319

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45847558&oldid=2086231649"